The Modernisation of Healthcare will be one of the Greatest Growth Drivers of the 21st Century NCL is a specialist healthcare investor. We create value by identifying companies who are at the forefront of transformational change. By applying the capital and human skills required to navigate this rapidly evolving sector, we prepare our companies to succeed both clinically and commercially. Our focus is on the pioneers. Companies that are actively using innovation and technological advancement to help prevent, treat and cure a wide range of conditions. Our mission is to address the challenges of our future health needs, whilst creating the next generation of valuable businesses.
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2010
Investment Type: Venture Capital
Portfolio 9
| Date | Name | Website | Total Raised | Location |
| - | Revolo Bio... | revolobio.... | $126.36M | United Sta... |
| - | Sana | sana.io | - | Belize, Co... |
| - | Centauri T... | centaurith... | $36.93M | United Kin... |
| - | Azadyne | azadyne.co... | - | - |
| - | Every woma... | viramal.co... | - | United Kin... |
| - | TC BioPhar... | tcbiopharm... | - | United Kin... |
| - | Ampersand ... | ampersandh... | - | - |
| - | Emteq | emteq.net | - | United Kin... |
| - | Curesponse | curesponse... | $14M | - |
News 24
| Date | Title | Description |
| 21.10.2020 | Research by emteq labs reveals how emotion measurement could... | The AI Journal has covered the latest research by portfolio Emteq, acknowledging their current succe... |
| 23.09.2020 | LifeArc and UK government’s Future Fund provide £3.0m in fun... | LifeArc, an independent medical research charity,announces a £3.0m co-investment in British biotech ... |
| 22.09.2020 | Immune Regulation Limited raises £40.6 million / $53.4 milli... | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of... |
| 17.09.2020 | Immune system ‘bully boys’ square up to coronavirus crisis... | Scalable, affordable, effective. Read about TC Biopharm’s stunning progress in the Financial Times h... |
| 01.07.2020 | TC BioPharm C-19 Therapy Trials Approved | Porfolio company TC BioPharm has had their T-cell therapy approved for trials in Scotland for Covid-... |
| 11.06.2020 | NCL is UK Lead of $6M Series A for Curesponse | NCL is delighted to welcome Curesponse to our portfolio, a breakthrough cancer precision medicine co... |
| 06.04.2020 | TC BioPharm to begin trialling T-cell therapy against Covid-... | Fantastic to see the Telegraph and the Daily Mail covering the work of TC BioPharm, one of our portf... |
| 17.09.2019 | Award for ALERT at product launch! | After an absolutely fantastic product launch last week, the team at Alert Technology are slowly co... |
| 13.08.2019 | The child who inspired Andiamo – London’s most exciting tech... | The agony suffered by tragic Diamo Parvez motivated parents Samiya and Naveed to alleviate the suffe... |
| 09.05.2019 | These face-reading glasses track physical and mental health | Surgeon Charles Nduka has developed sensor tech to track facial expressions and is currently using i... |
Show more